La vendita allo scoperto per Hain Celestial Group dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Hain Celestial Group. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Hain Celestial Group (NASDAQ:HAIN) Azioni, Report sulle vendite allo scoperto

Hain Celestial Group

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

The Hain Celestial Group, Inc. - Common Stock

The Hain Celestial Group Inc

HNA INFRA CO LTD ORD by HNA Infrastructure Co. Ltd.

Hainan Meilan International Airport Co Ltd

DA Davidson analyst Brian Holland maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Neutral and lowers the price target from $9 to $8.

News

Price Target

Analyst Ratings

HAIN

DA Davidson Maintains Neutral on Hain Celestial Group, Lowers Price Target to $8

5 analysts have shared their evaluations of Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.4, a high estimate of $9.00, and a low estimate of $8.00. Surpassing the previous average price target of $8.00, the current average has increased by 5.0%.
<img src="https://www.benzinga.com/files/images/story/2024/1731358819_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Hain Celestial Group among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Lazar</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Andrew Lazar</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Brian Holland</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Matthew Smith</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$9.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hain Celestial Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Hain Celestial Group compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Hain Celestial Group's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Hain Celestial Group's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HAIN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hain Celestial Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Hain Celestial Group</h2>
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby &amp; kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
<h3>A Deep Dive into Hain Celestial Group's Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Hain Celestial Group's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -6.48%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Hain Celestial Group's net margin excels beyond industry benchmarks, reaching -0.7%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Hain Celestial Group's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -0.31%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Hain Celestial Group's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.14%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.89.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Hain Celestial Group: 5 Analysts Share Their Views

Barclays analyst Andrew Lazar maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Equal-Weight and lowers the price target from $9 to $8.

Barclays Maintains Equal-Weight on Hain Celestial Group, Lowers Price Target to $8

<h3>Gainers</h3>
<ul>
<li>Webuy Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) stock moved upwards by 275.1% to $0.43 during Thursday's regular session. The market value of their outstanding shares is at $36.0 million. </li>
<li>22nd Century Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares rose 20.38% to $0.12. The company's market cap stands at $5.6 million. </li>
<li>Laird Superfood (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LSF#AMEX">LSF</a>) stock increased by 19.68% to $8.82. The company's market cap stands at $90.6 million. As per the news, the Q3 earnings report came out yesterday. </li>
<li>e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) shares increased by 17.25% to $122.13. The company's market cap stands at $6.8 billion. The company's, Q2 earnings came out yesterday. </li>
<li>WK Kellogg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLG#NYSE">KLG</a>) shares moved upwards by 15.49% to $19.45. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q3 earnings came out today. </li>
<li>DDC Enterprise (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DDC#AMEX">DDC</a>) stock increased by 12.88% to $0.19. The company's market cap stands at $4.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fresh Vine Wine (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VINE#AMEX">VINE</a>) shares fell 29.9% to $0.56 during Thursday's regular session. The market value of their outstanding shares is at $8.9 million. </li>
<li>Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) stock fell 15.45% to $7.53. The company's market cap stands at $676.0 million. The company's, Q1 earnings came out today. </li>
<li>Olaplex Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLPX#NASDAQ">OLPX</a>) shares fell 15.37% to $1.51. The company's market cap stands at $1.0 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Oatly Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLY#NASDAQ">OTLY</a>) stock decreased by 13.92% to $0.8. The company's market cap stands at $477.5 million. As per the news, the Q3 earnings report came out today. </li>
<li>Farmmi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAMI#NASDAQ">FAMI</a>) stock declined by 13.07% to $0.28. The market value of their outstanding shares is at $3.0 million. </li>
<li>SpartanNash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPTN#NASDAQ">SPTN</a>) shares declined by 10.75% to $20.16. The market value of their outstanding shares is at $680.3 million. As per the news, the Q3 earnings report came out today. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-defensive-stocks/" title="www.benzinga.com/money/best-consumer-defensive-stocks/">www.benzinga.com/money/best-consumer-defensive-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FAMI

OLPX

OTLY

SPTN

VINE

WBUY

XXII

12 Consumer Staples Stocks Moving In Thursday's Intraday Session

WIIM

Hain Celestial Group shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results.

Earnings

Earnings Beats

Earnings Misses

Hain Celestial Group Q1 2025 Adj. EPS $(0.04) Misses $(0.02) Estimate, Sales $394.596M Beat $394.317M Estimate

4 analysts have expressed a variety of opinions on Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.5, a high estimate of $9.00, and a low estimate of $8.00. Witnessing a positive shift, the current average has risen by 9.68% from the previous average price target of $7.75.
<img src="https://www.benzinga.com/files/images/story/2024/1726779681_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Hain Celestial Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Andrew Lazar</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Brian Holland</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Matthew Smith</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$9.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Hain Celestial Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hain Celestial Group compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Hain Celestial Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Hain Celestial Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HAIN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hain Celestial Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Hain Celestial Group</h2>
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby &amp; kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
<h3>Unraveling the Financial Story of Hain Celestial Group</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Hain Celestial Group's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -6.48%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Hain Celestial Group's net margin excels beyond industry benchmarks, reaching -0.7%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Hain Celestial Group's ROE stands out, surpassing industry averages. With an impressive ROE of -0.31%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Hain Celestial Group's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.14%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.89.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Hain Celestial Group: Insights From 4 Analyst Reviews

Piper Sandler analyst Michael Lavery maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Neutral and maintains $8 price target.

Piper Sandler Maintains Neutral on Hain Celestial Group, Maintains $8 Price Target

Barclays analyst Andrew Lazar maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Equal-Weight and raises the price target from $7 to $9.

Barclays Maintains Equal-Weight on Hain Celestial Group, Raises Price Target to $9

DA Davidson analyst Brian Holland maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Neutral and maintains $8 price target.

DA Davidson Maintains Neutral on Hain Celestial Group, Maintains $8 Price Target

U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Wednesday.
Shares of Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) rose during Wednesday's session following better-than-expected <a href="https://www.benzinga.com/news/earnings/24/08/40599429/kohls-q2-earnings-profit-beat-inventory-decline-margin-growth-and-more">second-quarter financial results.</a>
The company reported a net sales decline of 4.2% Y/Y to $3.525 billion, with comparable sales for the quarter decreasing 5.1% Y/Y. Total revenue stood at $3.732 billion. The analyst consensus estimate was $3.583 billion. EPS was 59 cents, beating the analyst consensus estimate of 44 cents.
Kohl&#8217;s shares climbed 5.6% to $20.71 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Waldencast plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WALD#NASDAQ">WALD</a>) jumped 41.5% to $4.0920 after the company reported second-quarter revenue growth.</li>
<li>AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) gained 17.6% to $209.40 after multiple analysts upgraded the stock and raised their price targets.</li>
<li>VNET Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) gained 17.1% to $2.34 following second-quarter results.</li>
<li>Xiao-I Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) rose 12.3% to $5.45.</li>
<li>Bioceres Crop Solutions Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOX#NASDAQ">BIOX</a>) climbed 12.1% to $11.32. Bioceres Crop Solutions received green light for cultivation of Drought Tolerant HB4 Wheat in the United States.</li>
<li>Ambarella, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) surged 11.3% to $58.82 after the company reported better-than-expected second-quarter adjusted EPS and sales.</li>
<li>Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) gained 10.1% to $31.73 after the company reported better-than-expected second-quarter financial results and issued FY25 guidance above estimates.</li>
<li>MannKind Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNKD#NASDAQ">MNKD</a>) jumped 10.2% to $5.93. Oppenheimer analyst Steven Lichtman maintained MannKind with an Outperform and raised the price target from $10 to $12.</li>
<li>Westrock Coffee Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEST#NASDAQ">WEST</a>) gained 9.9% to $9.35. Westrock Coffee Company commenced warrant exchange offer and consent solicitation.</li>
<li>The Hain Celestial Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) gained 10.2% to $8.93. Hain Celestial Group, on Tuesday, reported better-than-expected quarterly adjusted EPS results</li>
<li>AvePoint, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVPT#NASDAQ">AVPT</a>) jumped 8.5% to $11.69 after the company announced it commenced an offer to purchase all outstanding public warrants to purchase shares of its common stock at $2.50 per share without interest.</li>
<li>Chewy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) gained 8.2% to $28.04 following quarterly results.</li>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) gained 4.4% to $75.49. B of A Securities analyst Ruplu Bhattacharya upgraded Concentrix from Underperform to Neutral and raised the price target from $65 to $85.</li>
<li>Bristol-Myers Squibb Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) rose 3.3% to $49.68.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40600771/ambarella-to-rally-around-61-here-are-10-top-analyst-forecasts-for-wednesday">Ambarella To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Intraday Update

Markets

Trading Ideas

AIXI

AMBA

AVAV

AVPT

BIOX

CHWY

CNXC

MNKD

VNET

WALD

WEST

Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday

Stifel analyst Matthew Smith maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Hold and raises the price target from $8 to $9.

Stifel Maintains Hold on Hain Celestial Group, Raises Price Target to $9

The Hain Celestial Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hain#NASDAQ">HAIN</a>) posted fourth-quarter fiscal 2024 results, with the top line declining year over year but surpassing the Zacks Consensus Estimate. The bottom line rose year over year and beat the consensus mark.
The fiscal 2024 marked a pivotal year for the company&#39;s Hain Reimagined strategy, during which it made significant strides in simplifying its operations and driving growth. The transition to a global operating model helped reduce geographic complexity, enhance scale and foster a performance-driven, values-based culture. Looking ahead to the fiscal 2025, HAIN plans to focus on commercial execution to boost both top- and bottom-line growth. Management remains confident in the Hain Reimagined strategy, emphasizing the strength of the company&#39;s diversified portfolio and global footprint.
<h2>More on Hain Celestial&#39;s Q4 Financial Results</h2>
HAIN posted adjusted earnings of 13 cents per share, outpacing the Zacks Consensus Estimate of 8 cents. The bottom line increased from adjusted earnings of 11 cents reported in the year-ago quarter.
Net sales of $419 million beat the consensus estimate of $418.2 million. The top line declined 6% year over year. Organic sales fell 4% from the year-ago quarter&#39;s reported figure.
<div class="chart_embed">
<h3>The Hain Celestial Group, Inc. Price, Consensus and EPS Surprise</h3>
<img alt="The Hain Celestial Group, Inc. Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/1f/1724768862.png" style="height:268px; width:570px" title="" />
The Hain Celestial Group, Inc. price-consensus-eps-surprise-chart | The Hain Celestial Group, Inc. Quote
The adjusted gross profit of almost $98 million fell 3.7% from the year-ago quarter&#39;s figure. In comparison, the adjusted gross margin expanded 70 basis points (bps) from the year-ago quarter&#39;s reported figure to 23.4%. We had expected the adjusted gross margin to expand 40 bps to 23.1%.
</div>
SG&amp;A expenses came in at $72.3 million, up from $66.9 million reported in the year-ago quarter.
Adjusted EBITDA stood at $40 million down from $44 million reported in the year-ago quarter&#39;s reported figure. The adjusted EBITDA margin contracted 30 bps to 9.4%. We had expected an adjusted EBITDA margin contraction of 80 bps to 8.9%.
<h2>HAIN Provides Q4 Revenue &amp; Profit Insights by Segment</h2>
Net sales in the North America segment tumbled 8% from the year-ago quarter&#39;s reported figure to $260 million. Segmental organic net sales fell 5% year over year, mainly due to reduced personal care sales, partly owing to portfolio simplification and a decline in infant formula sales within the baby and kids category. This drop was partially offset by growth in the snacks segment. We expected North America&#39;s sales to fall 7.6% to $260.3 million in the reported quarter.
The segment&#39;s adjusted EBITDA amounted to $21 million, down from $27 million reported in the year-ago quarter. Adjusted EBITDA margin in the quarter dropped to 8% from 9.6% reported in the year-ago quarter.
The International segment&#39;s net sales fell 4% from the year-ago quarter&#39;s reported figure to $159 million. Segmental organic net sales also fell 4% year over year, primarily due to lower sales in plant-based meat alternatives within the meal prep category and a decline in snacks. The downside was partially offset by growth in the beverages segment. We had anticipated the segment&#39;s sales to decline 6.6% to $155.1 million in the reported quarter.
The segment&#39;s adjusted EBITDA was $27 million, flat year over year. Adjusted EBITDA margin in the quarter expanded 40 bps to 17%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/5e/75586.jpg?v=1083651962" />
Image Source: Zacks Investment Research
<h2>HAIN&#39;s Financial Snapshot: Cash, Debt and Equity Overview</h2>
The Zacks Rank #3 (Hold) company ended the reported quarter with cash and cash equivalents of $54.3 million, long-term debt (excluding the current portion) of $736.5 million and total shareholders&#39; equity of $942.9 million.
The company reported cash provided by operating activities of $39 million and a free cash flow of $31 million during the quarter under review.
<h2>What Lies Ahead For Hain Celestial?</h2>
For fiscal 2025, management expects organic net sales to be stable or show improvement year-over-year. Adjusted EBITDA is projected to grow by mid-single digits and gross margin is anticipated to rise by at least 125 basis points. Additionally, the company forecasts generating at least $60 million in free cash flow for the year.
The company&#39;s shares have dropped 3.1% in the past three months against the industry&#39;s 2.4% growth.
<h2>Stocks to Consider</h2>
The Chef&#39;s Warehouse (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chef#NASDAQ">CHEF</a>), which distributes specialty food products, currently sports a Zacks Rank #1 (Strong Buy). CHEF has a trailing four-quarter earnings surprise of 33.7%, on average.
The Zacks Consensus Estimate for The Chef&#39;s Warehouse&#39;s current fiscal year sales and earnings indicates growth of 9.7% and 12.6%, respectively, from the year-ago reported numbers.
Vital Farms (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vitl#NASDAQ">VITL</a>) offers a range of produced pasture-raised foods. It currently carries a Zacks Rank #2 (Buy). VITL has a trailing four-quarter earnings surprise of 82.5%, on average.
The Zacks Consensus Estimate for Vital Farms&#39; current financial-year sales and earnings indicate growth of 26.3% and 88.1%, respectively, from the prior-year reported level.
Nomad Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nomd#NYSE">NOMD</a>), carrying a Zacks Rank #2, manufactures and distributes frozen foods. NOMD has a trailing four-quarter earnings surprise of 3.1%, on average.
The Zacks Consensus Estimate for Nomad Foods&#39; current financial-year sales and earnings indicates growth of 4.3% and 11.5%, respectively, from the prior-year reported level.
<a href="https://www.zacks.com/stock/news/2327847/hain-celestial-q4-earnings-top-hain-reimagined-strategy-yields?cid=CS-BENZ-FT-analyst_blog|earnings_article-2327847">To read this article on Zacks.com click here.</a>

Mid Cap

Small Cap

Management

CHEF

NOMD

VITL

Hain Celestial Q4 Earnings Top, Hain Reimagined Strategy Yields

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling around 0.2% on Tuesday.
The Dow traded down 0.16% to 41,175.13 while the NASDAQ fell 0.03% to 17,720.68. The S&amp;P 500 also fell, dropping, 0.01% to 5,616.66.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40575289/jim-cramer-believes-in-dell-ceo-doesnt-like-b-g-foods">Jim Cramer Believes In Dell CEO, Doesn&#8217;t Like B&amp;G Foods</a>
Leading and Lagging Sectors Information technology shares climbed by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 0.6%.
Top Headline
Hain Celestial Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) reported better-than-expected quarterly results on Tuesday.
The company reported fourth quarter adjusted earnings per share of 13 cents, beating the analyst consensus estimate of 8 cents. Quarterly revenues of $418.80 million missed the street view of $421.2 million.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares shot up 43% to $0.6190 after the company received a $14 million multi-year grant from the NIH for the continued development of its PF614-MPAR, an abuse-deterrent opioid with overdose protection.</li>
<li>Shares of Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) got a boost, surging 39% to $10.40 after the company and Indivior selected clinical candidates from their GABAB positive allosteric modulator research collaboration. The company is eligible for up to $330 million on achievement of milestones and royalties.</li>
<li>VOXX International Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOXX#NASDAQ">VOXX</a>) shares were also up, gaining 70% to $4.8450 after announcing strategic alternatives process to maximize valuation.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Altisource Asset Management Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAMC#NASDAQ">AAMC</a>) shares dropped 48% to $1.2250 after the company announced intention to voluntarily delist and deregister its common stock from the NYSE American LLC.</li>
<li>Shares of COSCIENS Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCI#NASDAQ">CSCI</a>) were down 26% to $4.3350 after the company announced results from Phase 3 DETECT-trial of AEZS-130-P02.</li>
<li>American Woodmark Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMWD#NASDAQ">AMWD</a>) was down, falling 10% to $89.93 after the company reported worse-than-expected first-quarter financial results and expects FY25 sales to decline in low single digits.</li>
</ul>
Commodities In commodity news, oil traded down 1.8% to $76.02 while gold traded down 0.2% at $2,550.90.
Silver traded down 0.1% to $29.97 on Tuesday, while copper rose 0.6% to $4.3085.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.17%, Germany's DAX rose 0.40% and France's CAC 40 fell 0.17%. Spain's IBEX 35 Index rose 0.40%, while London's FTSE 100 rose 0.28%.
German economy contracted by 0.1% quarter-over-quarter in the second quarter, following a 0.2% growth in the first quarter. The GfK Consumer Climate Indicator for Germany fell to a reading of -22.0 heading into September compared to a revised -18.6 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.47%, Hong Kong's Hang Seng Index gaining 0.43%, China's Shanghai Composite Index falling 0.24% and India's BSE Sensex rising 0.02%.
Hong Kong&#8217;s trade deficit narrowed to $21.8 billion in July versus a $30 billion gap in the year-ago month, as exports increased more than imports.
Economics
<ul>
<li>The S&amp;P CoreLogic Case-Shiller home price index climbed by 6.5% year-over-year in June compared to a revised 6.9% rise in the prior month.</li>
<li>The FHFA house price index fell 0.1% in June, compared to market expectations for a 0.2% gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40574236/netflix-to-rally-around-9-here-are-10-top-analyst-forecasts-for-tuesday">Netflix To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Eurozone

AAMC

ADXN

AMWD

CSCI

ENSC

VOXX

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

U.S. stocks were mixed, with the Dow Jones index falling around 0.1% on Tuesday.
Shares of The Hain Celestial Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) shares gained 34.2% to $9.16 after the company reported better-than-expected fourth-quarter adjusted EPS results.
The company reported fourth quarter adjusted earnings per share of 13 cents, beating the analyst consensus estimate of 8 cents. Quarterly revenues of $418.80 million missed the street view of $421.2 million.
Hain Celestial shares jumped 34.2% to $9.16 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>ClearPoint Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) jumped 12.1% to $13.11. ClearPoint Neuro announced early repayment of $10 million note.</li>
<li>Trip.com Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) gained 8.6% to $45.98 following second-quarter financial results.</li>
<li>Evotec SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) gained 7.1% to $3.77.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) climbed 6.7% to $8.55.</li>
<li>Ryanair Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>) rose 5.5% to $110.01.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) surged 5.5% to $48.65. Soleno Therapeutics announced FDA acceptance for filing and priority review of its NDA for DCCR extended-release tablets for Prader-Willi Syndrome.</li>
<li>Energizer Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) gained 5.3% to $31.94 after Truist Securities upgraded the stock from Hold to Buy and raised its price target form $30 to $40.</li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40575289/jim-cramer-believes-in-dell-ceo-doesnt-like-b-g-foods">Jim Cramer Believes In Dell CEO, Doesn&#8217;t Like B&amp;G Foods</a></li>
</ul>

CLPT

RYAAY

SDST

SLNO

TCOM

Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday

The Hain Celestial Group shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results

The shares of the Hain Celestial Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) are <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/g40571984/hain-celestial-reports-fourth-quarter-and-fiscal-year-2024-financial-results" rel="noreferrer noopener">trading higher on Tuesday.</a>
The company reported fourth quarter adjusted earnings per share of 13 cents, beating the<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener"> analyst consensus estimate of 8 cents</a>. Quarterly revenues of $418.80 million missed the street view of $421.2 million.
Net sales slumped 6% year-over-year. Organic net sales decreased 4% compared to the prior year period.
Fiscal fourth quarter, organic net sales growth in the Snacks segment was flat year-over-year, the Baby &amp; Kids unit fell 10%, and Beverages registered net sales growth of 3% year-over-year. Personal care experienced a 17% year-over-year decline in organic net sales.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40554340/hain-celestial-gears-up-for-q4-print-here-are-the-recent-forecast-changes-from-wall-streets-most-ac" rel="noreferrer noopener">Hain Celestial Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a>
In the latest financial results for Hain Celestial Group, the adjusted gross profit margin increased by 70 basis points to 23.4% compared to the previous year.
Adjusted net income rose to $11 million, up from $10 million in the prior year. However, adjusted EBITDA decreased to $40 million from $44 million year-over-year, and the adjusted EBITDA margin declined by 30 basis points to 9.4%.
Outlook: The Hain Celestial Group anticipates organic net sales growth for FY25 to be flat or better. Additionally, the company expects its gross margin to increase by at least 125 basis points.
&#8220;Our fuel initiatives exceeded our targets for fiscal 2024, allowing us to pay down debt, invest in capabilities, and to deliver on our updated full-year guidance,&#8221; &nbsp;said Wendy Davidson, President and CEO.
Price Action: HAIN shares are trading higher by 8.20% to $7.39&nbsp;premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/08/40541938/nasa-chooses-spacex-over-boeing-for-stranded-astronauts-return-starliners-future-in-doubt" target="_blank" rel="noreferrer noopener">NASA Chooses SpaceX Over Boeing For Stranded Astronauts&#8217; Return: Starliner&#8217;s Future In Doubt</a></li>
</ul>

Guidance

General

Hain Celestial's Q4 EPS Beat And Optimistic FY25 Forecast Ignite Stock Surge: Details Here

The company is offering the following&nbsp;guidance&nbsp;for fiscal 2025:
<ul>
<li>Organic net sales growth is expected to be flat or better.The definition of organic net sales will be updated for fiscal 2025 to exclude the impact of foreign exchange in addition to the impact of acquisitions, divestitures, discontinued brands and exited product categories.&nbsp;&nbsp;</li>
<li>Adjusted EBITDA is expected to grow by mid-single-digits.</li>
<li>Gross margin is expected to increase by at least 125 basis points.</li>
<li>Free cash flow is expected to be at least&nbsp;$60 million.</li>
</ul>

The Hain Celestial Group Sees FY25 Organic Net Sales Growth To Be Flat Or Better (Prior View: Down 3%-4% YoY); Gross Margin Is Expected To Increase By At Least 125 Basis Points

Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.08 by 62.5 percent. This is a 18.18 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $418.80 million which missed the analyst consensus estimate of $421.21 million by 0.57 percent. This is a 6.48 percent decrease over sales of $447.84 million the same period last year.

Hain Celestial Group Q4 Adj $0.13 Beats $0.08 Estimate, Sales $418.80M Miss $421.21M Estimate

The Hain Celestial Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hain#NASDAQ">HAIN</a>) is likely to register top- and bottom-line decline when it reports fourth-quarter fiscal 2024 earnings on Aug 27. The Zacks Consensus Estimate for revenues is pegged at $418.2 million, suggesting a decrease of 6.6% from the prior-year quarter&#39;s reported figure. The consensus mark for HAIN&#39;s fiscal 2024 revenues is pegged at $1.7 billion, indicating a 3.4% decline from the year-ago period&#39;s reported figure.
The Zacks Consensus Estimate for quarterly earnings has remained unchanged in the past 30 days at 8 cents per share, suggesting a decline of 27.3% from the year-ago quarter&#39;s reported figure. The consensus mark for HAIN&#39;s fiscal 2024 earnings is pegged at 29 cents per share, indicating a 42% slump from the year-ago period&#39;s reported figure. HAIN has a trailing four-quarter earnings surprise of 32%, on average.
<h2>Things To Note</h2>
Hain Celestial is witnessing a persistent weakness in the North America unit, stemming from softness in the baby and kids category. In addition, prolonged stabilization in the Personal Care segment is exerting pressure on the company&#39;s performance. Slower-than-anticipated rebound in the infant formula division and snacks categories are further complicating matters. The continuation of these challenges into the fiscal fourth quarter is likely to have negatively impacted sales and overall performance. Our model suggests a 7.3% organic sales decline in the North America segment for the to-be-reported quarter.
For the fiscal 2024, management projects organic sales decline of 3-4% year over year. We expect an organic sales decline of 4.4% in the fiscal 2024. The company expects full-year adjusted EBITDA between $150 million and $155 million, reflecting a year-over-year decline.
<div class="chart_embed">
<h3>The Hain Celestial Group, Inc. Price and EPS Surprise</h3>
<img alt="The Hain Celestial Group, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/e2/1724675858.png" style="height:266px; width:531px" title="" />
The Hain Celestial Group, Inc. price-eps-surprise | The Hain Celestial Group, Inc. Quote
That being said, strength in its multi-year Reimagined strategy is likely to have aided its performance. Also, strength in Hain Celestial&#39;s International segment has been offering respite. Our model suggests the International segment&#39;s sales to be $676.8 million in the fiscal 2024, calling for a rise of 2.9% year over year.
</div>
<h2>What the Zacks Model Unveils</h2>
Our proven model doesn&#39;t conclusively predict an earnings beat for Hain Celestial this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
Hain Celestial carries a Zacks Rank #3 and has an Earnings ESP of 0.00%.
<h2>Some Stocks With Favorable Combination</h2>
Here are some companies worth considering, as our model shows that these, too, have the correct combination to beat on earnings this time around.
American Eagle Outfitters&nbsp;currently has an Earnings ESP of +1.97% and a Zacks Rank of 3. The company is likely to register bottom- and top-line growth when it reports second-quarter fiscal 2024 results. The consensus mark for AEO&#39;s quarterly revenues is pegged at $1.3 billion, indicating an 8.7% rise from the figure reported in the prior-year quarter.
The consensus mark for AEO&#39;s quarterly earnings has moved up a penny in the past 30 days to 38 cents. The consensus estimate indicates growth of 52% from the year-ago quarter&#39;s actual.
Costco Wholesale Corporation&nbsp;currently has an Earnings ESP of +0.89% and a Zacks Rank of 3. The company is expected to register top- and bottom-line growth when it reports fourth-quarter fiscal 2024 numbers. The Zacks Consensus Estimate for COST&#39;s quarterly revenues is pegged at $80.1 billion, suggesting growth of 1.4% from the year-ago quarter&#39;s reported figure.
The consensus estimate for Costco&#39;s earnings has remained unchanged in the past 30 days at $5.02. The consensus mark for earnings indicates growth of 3.3% from the year-ago quarter&#39;s reported figure. COST delivered an earnings beat of 2.3%, on average, in the trailing four quarters.
Burlington Stores has an Earnings ESP of +2.68% and a Zacks Rank of 3 at present. BURL is expected to register top- and bottom-line growth when it posts second-quarter fiscal 2024 numbers. The Zacks Consensus Estimate for its quarterly earnings has increased by a penny in the past seven days to 95 cents. The consensus mark for earnings indicates a 58.3% surge from the figure reported in the year-ago quarter.
The consensus estimate for quarterly revenues is pegged at $2.42 billion, calling for a rise of 11.2% from the top line reported in the year-ago quarter. BURL delivered a trailing four-quarter average earnings surprise of 21.7%.
<a href="https://www.zacks.com/stock/news/2327130/hain-celestial-hain-gears-up-for-q4-earnings-things-to-note?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2327130">To read this article on Zacks.com click here.</a>

Hain Celestial Gears Up for Q4 Earnings: Things to Note

The Hain Celestial Group, Inc. (HAIN) Q1 2025 Earnings Call Transcript

The Hain Celestial ( ($HAIN) ) has released its Q1 earnings. Here is a breakdown of the information The Hain Celestial presented to its investors. ...

Hain Celestial: Strategic Focus Amid Q1 Sales Decline

In a report released today, Matthew Smith, CFA from Stifel Nicolaus maintained a Hold rating on Hain Celestial (HAIN – Research Report), with a pri...

Stifel Nicolaus Keeps Their Hold Rating on Hain Celestial (HAIN)

In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Hain Celestial (HAIN – Research Report), with a price ...

Hain Celestial: Strategic Growth and Operational Streamlining Justify Buy Rating with $15 Price Target

Analysts fell to the sidelines weighing in on Hain Celestial (HAIN – Research Report) and Edgewell Personal Care (EPC – Research Report) with neutr...

Analysts Offer Insights on Consumer Goods Companies: Hain Celestial (HAIN) and Edgewell Personal Care (EPC)

Barclays lowered the firm's price target on Hain Celestial (HAIN) to $8 from $9 and keeps an Equal Weight rating on the shares. While Hain's guidan...

Hain Celestial price target lowered to $8 from $9 at Barclays

DA Davidson analyst Brian Holland lowered the firm's price target on Hain Celestial (HAIN) to $8 from $9 and keeps a Neutral rating on the shares a...

Hain Celestial price target lowered to $8 from $9 at DA Davidson

Hain Celestial: An Interesting Turnaround Bet

Vital Farms: Time To Look Elsewhere For Strong Upside

SunOpta: Not As Sweet As I Thought (Rating Downgrade)

AGRO

BRCC

DANOY

GPDNF

NSRGF

NSRGY

STKL

Press Releases

Hain Celestial To Participate in Upcoming Investor Conferences

Hain Celestial Unlocks Fuel For Growth Through Productivity and Sourcing, Cash Management and Operational Efficiencies

Hain Celestial Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Hain Celestial Completes the Sale of ParmCrisps® Snack Brand to Our Home

Hain Celestial Spices Up Your Fall Pantry with Seasonal, Better-For-You Snacks and Sips

Hain Celestial Announces Fiscal First Quarter 2025 Results Conference Call and Webcast

Celestial Seasonings Invites Tea Drinkers to "Taste Our World" in New Creative Campaign

Celestial Seasonings® Tea Announces Two New Innovations

Hain Celestial Reports Fiscal First Quarter 2025 Financial Results

Forafric Global

Adecoagro

Mission Produce

B&G Foods

Bridgford Foods Corporation - Common Stock

Bridgford Foods

Beyond Meat

Calavo Growers

Dole

John B. Sanfilippo & Son, Inc. - Common Stock

John B Sanfilippo & Son

J&J Snack Foods

WK Kellogg

Laird Superfood

Lifeway Foods

Mama`s Creations

Nomad Foods

Oriental Rise Holdings Limited - Ordinary Shares

Oriental Rise Holdings

Oatly Group AB - American Depositary Shares

Oatly Group

Seaboard

Seneca Foods Corp. - Class A Common Stock

Seneca Foods

Treehouse Foods

Tootsie Roll Industries, Inc. Common Stock

Comments

Hain Celestial Group

Vendite allo scoperto

Hain Celestial Group (NASDAQ:HAIN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO